nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—ADRA1B—vas deferens—testicular cancer	0.136	0.404	CbGeAlD
Cabergoline—HTR7—vas deferens—testicular cancer	0.0794	0.235	CbGeAlD
Cabergoline—HTR7—vein—testicular cancer	0.0337	0.1	CbGeAlD
Cabergoline—HTR2A—vein—testicular cancer	0.021	0.0624	CbGeAlD
Cabergoline—DRD4—testis—testicular cancer	0.00993	0.0294	CbGeAlD
Cabergoline—DRD5—female gonad—testicular cancer	0.00737	0.0219	CbGeAlD
Cabergoline—ADRA2C—seminal vesicle—testicular cancer	0.00551	0.0163	CbGeAlD
Cabergoline—ADRA2A—seminal vesicle—testicular cancer	0.0044	0.013	CbGeAlD
Cabergoline—HTR7—gonad—testicular cancer	0.00433	0.0128	CbGeAlD
Cabergoline—HTR2A—embryo—testicular cancer	0.00398	0.0118	CbGeAlD
Cabergoline—ADRA2C—female gonad—testicular cancer	0.00324	0.0096	CbGeAlD
Cabergoline—ADRA2A—gonad—testicular cancer	0.00318	0.00942	CbGeAlD
Cabergoline—HTR7—testis—testicular cancer	0.00312	0.00926	CbGeAlD
Cabergoline—DRD2—testis—testicular cancer	0.00295	0.00875	CbGeAlD
Cabergoline—ADRA2C—testis—testicular cancer	0.00287	0.00851	CbGeAlD
Cabergoline—HTR2A—gonad—testicular cancer	0.0027	0.00801	CbGeAlD
Cabergoline—HTR2B—lymph node—testicular cancer	0.00264	0.00784	CbGeAlD
Cabergoline—ADRA2A—female gonad—testicular cancer	0.00258	0.00766	CbGeAlD
Cabergoline—ADRA2A—testis—testicular cancer	0.00229	0.00679	CbGeAlD
Cabergoline—ADRA2C—lymph node—testicular cancer	0.00208	0.00617	CbGeAlD
Cabergoline—HTR2A—testis—testicular cancer	0.00195	0.00577	CbGeAlD
Cabergoline—ADRA2A—lymph node—testicular cancer	0.00166	0.00492	CbGeAlD
Cabergoline—Malaise—Etoposide—testicular cancer	0.00122	0.00184	CcSEcCtD
Cabergoline—Face oedema—Epirubicin—testicular cancer	0.00121	0.00183	CcSEcCtD
Cabergoline—Vertigo—Etoposide—testicular cancer	0.00121	0.00183	CcSEcCtD
Cabergoline—Decreased appetite—Ifosfamide—testicular cancer	0.00121	0.00183	CcSEcCtD
Cabergoline—Headache—Vinblastine—testicular cancer	0.00121	0.00183	CcSEcCtD
Cabergoline—Abdominal pain—Dactinomycin—testicular cancer	0.0012	0.00182	CcSEcCtD
Cabergoline—Fatigue—Ifosfamide—testicular cancer	0.0012	0.00181	CcSEcCtD
Cabergoline—Oedema—Cisplatin—testicular cancer	0.0012	0.00181	CcSEcCtD
Cabergoline—Hypersensitivity—Bleomycin—testicular cancer	0.0012	0.00181	CcSEcCtD
Cabergoline—Pain—Ifosfamide—testicular cancer	0.00119	0.0018	CcSEcCtD
Cabergoline—Constipation—Ifosfamide—testicular cancer	0.00119	0.0018	CcSEcCtD
Cabergoline—Cardiac failure—Doxorubicin—testicular cancer	0.00119	0.0018	CcSEcCtD
Cabergoline—Loss of consciousness—Etoposide—testicular cancer	0.00119	0.00179	CcSEcCtD
Cabergoline—Blood creatinine increased—Epirubicin—testicular cancer	0.00118	0.00178	CcSEcCtD
Cabergoline—Asthenia—Bleomycin—testicular cancer	0.00117	0.00177	CcSEcCtD
Cabergoline—Hypertension—Etoposide—testicular cancer	0.00117	0.00176	CcSEcCtD
Cabergoline—Osteoarthritis—Doxorubicin—testicular cancer	0.00116	0.00175	CcSEcCtD
Cabergoline—Hyperhidrosis—Cisplatin—testicular cancer	0.00116	0.00175	CcSEcCtD
Cabergoline—Liver function test abnormal—Epirubicin—testicular cancer	0.00116	0.00175	CcSEcCtD
Cabergoline—Pruritus—Bleomycin—testicular cancer	0.00116	0.00174	CcSEcCtD
Cabergoline—Feeling abnormal—Ifosfamide—testicular cancer	0.00115	0.00173	CcSEcCtD
Cabergoline—Nausea—Vinblastine—testicular cancer	0.00115	0.00173	CcSEcCtD
Cabergoline—Orthostatic hypotension—Epirubicin—testicular cancer	0.00115	0.00173	CcSEcCtD
Cabergoline—Abdominal pain upper—Epirubicin—testicular cancer	0.00115	0.00173	CcSEcCtD
Cabergoline—Anorexia—Cisplatin—testicular cancer	0.00115	0.00173	CcSEcCtD
Cabergoline—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00114	0.00172	CcSEcCtD
Cabergoline—Discomfort—Etoposide—testicular cancer	0.00114	0.00171	CcSEcCtD
Cabergoline—Hypotension—Cisplatin—testicular cancer	0.00112	0.0017	CcSEcCtD
Cabergoline—Face oedema—Doxorubicin—testicular cancer	0.00112	0.00169	CcSEcCtD
Cabergoline—Hypersensitivity—Dactinomycin—testicular cancer	0.00112	0.00169	CcSEcCtD
Cabergoline—Abdominal discomfort—Methotrexate—testicular cancer	0.00111	0.00168	CcSEcCtD
Cabergoline—Gastritis—Epirubicin—testicular cancer	0.00111	0.00168	CcSEcCtD
Cabergoline—Confusional state—Etoposide—testicular cancer	0.00111	0.00168	CcSEcCtD
Cabergoline—Abdominal pain—Ifosfamide—testicular cancer	0.0011	0.00166	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.0011	0.00165	CcSEcCtD
Cabergoline—Asthenia—Dactinomycin—testicular cancer	0.00109	0.00165	CcSEcCtD
Cabergoline—Blood creatinine increased—Doxorubicin—testicular cancer	0.00109	0.00164	CcSEcCtD
Cabergoline—Influenza—Epirubicin—testicular cancer	0.00109	0.00164	CcSEcCtD
Cabergoline—Paraesthesia—Cisplatin—testicular cancer	0.00108	0.00163	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00108	0.00163	CcSEcCtD
Cabergoline—Liver function test abnormal—Doxorubicin—testicular cancer	0.00107	0.00162	CcSEcCtD
Cabergoline—Dyspnoea—Cisplatin—testicular cancer	0.00107	0.00162	CcSEcCtD
Cabergoline—Hyperhidrosis—Etoposide—testicular cancer	0.00107	0.00161	CcSEcCtD
Cabergoline—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00106	0.0016	CcSEcCtD
Cabergoline—Abdominal pain upper—Doxorubicin—testicular cancer	0.00106	0.0016	CcSEcCtD
Cabergoline—Anorexia—Etoposide—testicular cancer	0.00105	0.00158	CcSEcCtD
Cabergoline—Decreased appetite—Cisplatin—testicular cancer	0.00105	0.00158	CcSEcCtD
Cabergoline—Bronchitis—Epirubicin—testicular cancer	0.00104	0.00158	CcSEcCtD
Cabergoline—Diarrhoea—Dactinomycin—testicular cancer	0.00104	0.00157	CcSEcCtD
Cabergoline—Pneumonia—Methotrexate—testicular cancer	0.00104	0.00157	CcSEcCtD
Cabergoline—Vomiting—Bleomycin—testicular cancer	0.00104	0.00157	CcSEcCtD
Cabergoline—Depression—Methotrexate—testicular cancer	0.00103	0.00156	CcSEcCtD
Cabergoline—Hypotension—Etoposide—testicular cancer	0.00103	0.00155	CcSEcCtD
Cabergoline—Rash—Bleomycin—testicular cancer	0.00103	0.00155	CcSEcCtD
Cabergoline—Gastritis—Doxorubicin—testicular cancer	0.00103	0.00155	CcSEcCtD
Cabergoline—Pain—Cisplatin—testicular cancer	0.00103	0.00155	CcSEcCtD
Cabergoline—Dermatitis—Bleomycin—testicular cancer	0.00103	0.00155	CcSEcCtD
Cabergoline—Hypersensitivity—Ifosfamide—testicular cancer	0.00103	0.00155	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00101	0.00152	CcSEcCtD
Cabergoline—Influenza—Doxorubicin—testicular cancer	0.00101	0.00152	CcSEcCtD
Cabergoline—Asthenia—Ifosfamide—testicular cancer	0.001	0.00151	CcSEcCtD
Cabergoline—Feeling abnormal—Cisplatin—testicular cancer	0.000991	0.0015	CcSEcCtD
Cabergoline—Paraesthesia—Etoposide—testicular cancer	0.00099	0.00149	CcSEcCtD
Cabergoline—Weight increased—Epirubicin—testicular cancer	0.000989	0.00149	CcSEcCtD
Cabergoline—Pruritus—Ifosfamide—testicular cancer	0.000987	0.00149	CcSEcCtD
Cabergoline—Weight decreased—Epirubicin—testicular cancer	0.000983	0.00148	CcSEcCtD
Cabergoline—Dyspnoea—Etoposide—testicular cancer	0.000983	0.00148	CcSEcCtD
Cabergoline—Somnolence—Etoposide—testicular cancer	0.00098	0.00148	CcSEcCtD
Cabergoline—Epistaxis—Methotrexate—testicular cancer	0.000976	0.00147	CcSEcCtD
Cabergoline—Pneumonia—Epirubicin—testicular cancer	0.000974	0.00147	CcSEcCtD
Cabergoline—Nausea—Bleomycin—testicular cancer	0.00097	0.00146	CcSEcCtD
Cabergoline—Vomiting—Dactinomycin—testicular cancer	0.000968	0.00146	CcSEcCtD
Cabergoline—Bronchitis—Doxorubicin—testicular cancer	0.000967	0.00146	CcSEcCtD
Cabergoline—Rash—Dactinomycin—testicular cancer	0.00096	0.00145	CcSEcCtD
Cabergoline—Decreased appetite—Etoposide—testicular cancer	0.000958	0.00145	CcSEcCtD
Cabergoline—Diarrhoea—Ifosfamide—testicular cancer	0.000955	0.00144	CcSEcCtD
Cabergoline—Fatigue—Etoposide—testicular cancer	0.00095	0.00143	CcSEcCtD
Cabergoline—Pain—Etoposide—testicular cancer	0.000942	0.00142	CcSEcCtD
Cabergoline—Constipation—Etoposide—testicular cancer	0.000942	0.00142	CcSEcCtD
Cabergoline—Urinary tract infection—Epirubicin—testicular cancer	0.000942	0.00142	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000934	0.00141	CcSEcCtD
Cabergoline—Dizziness—Ifosfamide—testicular cancer	0.000923	0.00139	CcSEcCtD
Cabergoline—Weight increased—Doxorubicin—testicular cancer	0.000915	0.00138	CcSEcCtD
Cabergoline—Epistaxis—Epirubicin—testicular cancer	0.000914	0.00138	CcSEcCtD
Cabergoline—Weight decreased—Doxorubicin—testicular cancer	0.000909	0.00137	CcSEcCtD
Cabergoline—Feeling abnormal—Etoposide—testicular cancer	0.000908	0.00137	CcSEcCtD
Cabergoline—Nausea—Dactinomycin—testicular cancer	0.000904	0.00136	CcSEcCtD
Cabergoline—Pneumonia—Doxorubicin—testicular cancer	0.000901	0.00136	CcSEcCtD
Cabergoline—Gastrointestinal pain—Etoposide—testicular cancer	0.000901	0.00136	CcSEcCtD
Cabergoline—Visual impairment—Methotrexate—testicular cancer	0.000895	0.00135	CcSEcCtD
Cabergoline—Vomiting—Ifosfamide—testicular cancer	0.000887	0.00134	CcSEcCtD
Cabergoline—Hypersensitivity—Cisplatin—testicular cancer	0.000886	0.00134	CcSEcCtD
Cabergoline—Rash—Ifosfamide—testicular cancer	0.00088	0.00133	CcSEcCtD
Cabergoline—Dermatitis—Ifosfamide—testicular cancer	0.000879	0.00133	CcSEcCtD
Cabergoline—Rhinitis—Epirubicin—testicular cancer	0.000872	0.00132	CcSEcCtD
Cabergoline—Abdominal pain—Etoposide—testicular cancer	0.000871	0.00131	CcSEcCtD
Cabergoline—Urinary tract infection—Doxorubicin—testicular cancer	0.000871	0.00131	CcSEcCtD
Cabergoline—Asthenia—Cisplatin—testicular cancer	0.000863	0.0013	CcSEcCtD
Cabergoline—Cardiac disorder—Methotrexate—testicular cancer	0.000862	0.0013	CcSEcCtD
Cabergoline—Oedema peripheral—Epirubicin—testicular cancer	0.000857	0.00129	CcSEcCtD
Cabergoline—Epistaxis—Doxorubicin—testicular cancer	0.000845	0.00128	CcSEcCtD
Cabergoline—Visual impairment—Epirubicin—testicular cancer	0.000838	0.00126	CcSEcCtD
Cabergoline—Nausea—Ifosfamide—testicular cancer	0.000829	0.00125	CcSEcCtD
Cabergoline—Diarrhoea—Cisplatin—testicular cancer	0.000823	0.00124	CcSEcCtD
Cabergoline—Alopecia—Methotrexate—testicular cancer	0.000821	0.00124	CcSEcCtD
Cabergoline—Hypersensitivity—Etoposide—testicular cancer	0.000812	0.00122	CcSEcCtD
Cabergoline—Cardiac disorder—Epirubicin—testicular cancer	0.000807	0.00122	CcSEcCtD
Cabergoline—Rhinitis—Doxorubicin—testicular cancer	0.000807	0.00122	CcSEcCtD
Cabergoline—Oedema peripheral—Doxorubicin—testicular cancer	0.000793	0.0012	CcSEcCtD
Cabergoline—Asthenia—Etoposide—testicular cancer	0.000791	0.00119	CcSEcCtD
Cabergoline—Back pain—Methotrexate—testicular cancer	0.000782	0.00118	CcSEcCtD
Cabergoline—Pruritus—Etoposide—testicular cancer	0.00078	0.00118	CcSEcCtD
Cabergoline—Arrhythmia—Epirubicin—testicular cancer	0.000777	0.00117	CcSEcCtD
Cabergoline—Visual impairment—Doxorubicin—testicular cancer	0.000775	0.00117	CcSEcCtD
Cabergoline—Alopecia—Epirubicin—testicular cancer	0.000768	0.00116	CcSEcCtD
Cabergoline—Vomiting—Cisplatin—testicular cancer	0.000765	0.00115	CcSEcCtD
Cabergoline—Rash—Cisplatin—testicular cancer	0.000758	0.00114	CcSEcCtD
Cabergoline—Dermatitis—Cisplatin—testicular cancer	0.000758	0.00114	CcSEcCtD
Cabergoline—Diarrhoea—Etoposide—testicular cancer	0.000754	0.00114	CcSEcCtD
Cabergoline—Ill-defined disorder—Methotrexate—testicular cancer	0.00075	0.00113	CcSEcCtD
Cabergoline—Cardiac disorder—Doxorubicin—testicular cancer	0.000747	0.00113	CcSEcCtD
Cabergoline—Flatulence—Epirubicin—testicular cancer	0.000746	0.00113	CcSEcCtD
Cabergoline—Tension—Epirubicin—testicular cancer	0.000743	0.00112	CcSEcCtD
Cabergoline—Nervousness—Epirubicin—testicular cancer	0.000735	0.00111	CcSEcCtD
Cabergoline—Back pain—Epirubicin—testicular cancer	0.000732	0.0011	CcSEcCtD
Cabergoline—Malaise—Methotrexate—testicular cancer	0.000729	0.0011	CcSEcCtD
Cabergoline—Dizziness—Etoposide—testicular cancer	0.000729	0.0011	CcSEcCtD
Cabergoline—Muscle spasms—Epirubicin—testicular cancer	0.000728	0.0011	CcSEcCtD
Cabergoline—Vertigo—Methotrexate—testicular cancer	0.000727	0.0011	CcSEcCtD
Cabergoline—Arrhythmia—Doxorubicin—testicular cancer	0.000719	0.00108	CcSEcCtD
Cabergoline—Nausea—Cisplatin—testicular cancer	0.000715	0.00108	CcSEcCtD
Cabergoline—Alopecia—Doxorubicin—testicular cancer	0.000711	0.00107	CcSEcCtD
Cabergoline—Ill-defined disorder—Epirubicin—testicular cancer	0.000702	0.00106	CcSEcCtD
Cabergoline—Vomiting—Etoposide—testicular cancer	0.000701	0.00106	CcSEcCtD
Cabergoline—Rash—Etoposide—testicular cancer	0.000695	0.00105	CcSEcCtD
Cabergoline—Dermatitis—Etoposide—testicular cancer	0.000694	0.00105	CcSEcCtD
Cabergoline—Headache—Etoposide—testicular cancer	0.00069	0.00104	CcSEcCtD
Cabergoline—Flatulence—Doxorubicin—testicular cancer	0.00069	0.00104	CcSEcCtD
Cabergoline—Arthralgia—Methotrexate—testicular cancer	0.000689	0.00104	CcSEcCtD
Cabergoline—Tension—Doxorubicin—testicular cancer	0.000687	0.00104	CcSEcCtD
Cabergoline—Malaise—Epirubicin—testicular cancer	0.000683	0.00103	CcSEcCtD
Cabergoline—Discomfort—Methotrexate—testicular cancer	0.00068	0.00103	CcSEcCtD
Cabergoline—Nervousness—Doxorubicin—testicular cancer	0.00068	0.00103	CcSEcCtD
Cabergoline—Vertigo—Epirubicin—testicular cancer	0.00068	0.00103	CcSEcCtD
Cabergoline—Syncope—Epirubicin—testicular cancer	0.000679	0.00102	CcSEcCtD
Cabergoline—Back pain—Doxorubicin—testicular cancer	0.000677	0.00102	CcSEcCtD
Cabergoline—Muscle spasms—Doxorubicin—testicular cancer	0.000673	0.00102	CcSEcCtD
Cabergoline—Palpitations—Epirubicin—testicular cancer	0.000669	0.00101	CcSEcCtD
Cabergoline—Confusional state—Methotrexate—testicular cancer	0.000666	0.001	CcSEcCtD
Cabergoline—Loss of consciousness—Epirubicin—testicular cancer	0.000665	0.001	CcSEcCtD
Cabergoline—Nausea—Etoposide—testicular cancer	0.000655	0.000988	CcSEcCtD
Cabergoline—Hypertension—Epirubicin—testicular cancer	0.000654	0.000986	CcSEcCtD
Cabergoline—Ill-defined disorder—Doxorubicin—testicular cancer	0.00065	0.00098	CcSEcCtD
Cabergoline—Arthralgia—Epirubicin—testicular cancer	0.000644	0.000972	CcSEcCtD
Cabergoline—Anxiety—Epirubicin—testicular cancer	0.000642	0.000969	CcSEcCtD
Cabergoline—Hyperhidrosis—Methotrexate—testicular cancer	0.000638	0.000963	CcSEcCtD
Cabergoline—Discomfort—Epirubicin—testicular cancer	0.000637	0.000961	CcSEcCtD
Cabergoline—Malaise—Doxorubicin—testicular cancer	0.000632	0.000953	CcSEcCtD
Cabergoline—Dry mouth—Epirubicin—testicular cancer	0.00063	0.000951	CcSEcCtD
Cabergoline—Vertigo—Doxorubicin—testicular cancer	0.000629	0.000949	CcSEcCtD
Cabergoline—Anorexia—Methotrexate—testicular cancer	0.000629	0.000949	CcSEcCtD
Cabergoline—Syncope—Doxorubicin—testicular cancer	0.000628	0.000948	CcSEcCtD
Cabergoline—Confusional state—Epirubicin—testicular cancer	0.000623	0.00094	CcSEcCtD
Cabergoline—Palpitations—Doxorubicin—testicular cancer	0.000619	0.000934	CcSEcCtD
Cabergoline—Oedema—Epirubicin—testicular cancer	0.000618	0.000932	CcSEcCtD
Cabergoline—Hypotension—Methotrexate—testicular cancer	0.000617	0.000931	CcSEcCtD
Cabergoline—Loss of consciousness—Doxorubicin—testicular cancer	0.000616	0.000929	CcSEcCtD
Cabergoline—Shock—Epirubicin—testicular cancer	0.000608	0.000917	CcSEcCtD
Cabergoline—Hypertension—Doxorubicin—testicular cancer	0.000605	0.000912	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000601	0.000907	CcSEcCtD
Cabergoline—Hyperhidrosis—Epirubicin—testicular cancer	0.000597	0.000901	CcSEcCtD
Cabergoline—Insomnia—Methotrexate—testicular cancer	0.000597	0.000901	CcSEcCtD
Cabergoline—Arthralgia—Doxorubicin—testicular cancer	0.000596	0.0009	CcSEcCtD
Cabergoline—Anxiety—Doxorubicin—testicular cancer	0.000594	0.000896	CcSEcCtD
Cabergoline—Paraesthesia—Methotrexate—testicular cancer	0.000593	0.000894	CcSEcCtD
Cabergoline—Discomfort—Doxorubicin—testicular cancer	0.000589	0.000889	CcSEcCtD
Cabergoline—Anorexia—Epirubicin—testicular cancer	0.000589	0.000888	CcSEcCtD
Cabergoline—Dyspnoea—Methotrexate—testicular cancer	0.000589	0.000888	CcSEcCtD
Cabergoline—Somnolence—Methotrexate—testicular cancer	0.000587	0.000885	CcSEcCtD
Cabergoline—Dry mouth—Doxorubicin—testicular cancer	0.000583	0.00088	CcSEcCtD
Cabergoline—Dyspepsia—Methotrexate—testicular cancer	0.000581	0.000877	CcSEcCtD
Cabergoline—Hypotension—Epirubicin—testicular cancer	0.000577	0.000871	CcSEcCtD
Cabergoline—Confusional state—Doxorubicin—testicular cancer	0.000576	0.00087	CcSEcCtD
Cabergoline—Decreased appetite—Methotrexate—testicular cancer	0.000574	0.000866	CcSEcCtD
Cabergoline—Oedema—Doxorubicin—testicular cancer	0.000572	0.000862	CcSEcCtD
Cabergoline—Fatigue—Methotrexate—testicular cancer	0.000569	0.000859	CcSEcCtD
Cabergoline—Pain—Methotrexate—testicular cancer	0.000565	0.000852	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000563	0.000849	CcSEcCtD
Cabergoline—Shock—Doxorubicin—testicular cancer	0.000562	0.000848	CcSEcCtD
Cabergoline—Insomnia—Epirubicin—testicular cancer	0.000559	0.000843	CcSEcCtD
Cabergoline—Paraesthesia—Epirubicin—testicular cancer	0.000555	0.000837	CcSEcCtD
Cabergoline—Hyperhidrosis—Doxorubicin—testicular cancer	0.000553	0.000834	CcSEcCtD
Cabergoline—Dyspnoea—Epirubicin—testicular cancer	0.000551	0.000831	CcSEcCtD
Cabergoline—Somnolence—Epirubicin—testicular cancer	0.000549	0.000829	CcSEcCtD
Cabergoline—Anorexia—Doxorubicin—testicular cancer	0.000545	0.000822	CcSEcCtD
Cabergoline—Feeling abnormal—Methotrexate—testicular cancer	0.000544	0.000821	CcSEcCtD
Cabergoline—Dyspepsia—Epirubicin—testicular cancer	0.000544	0.00082	CcSEcCtD
Cabergoline—Gastrointestinal pain—Methotrexate—testicular cancer	0.00054	0.000814	CcSEcCtD
Cabergoline—Decreased appetite—Epirubicin—testicular cancer	0.000537	0.00081	CcSEcCtD
Cabergoline—Hypotension—Doxorubicin—testicular cancer	0.000534	0.000806	CcSEcCtD
Cabergoline—Fatigue—Epirubicin—testicular cancer	0.000533	0.000804	CcSEcCtD
Cabergoline—Constipation—Epirubicin—testicular cancer	0.000528	0.000797	CcSEcCtD
Cabergoline—Pain—Epirubicin—testicular cancer	0.000528	0.000797	CcSEcCtD
Cabergoline—Abdominal pain—Methotrexate—testicular cancer	0.000522	0.000787	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000521	0.000786	CcSEcCtD
Cabergoline—Insomnia—Doxorubicin—testicular cancer	0.000517	0.00078	CcSEcCtD
Cabergoline—Paraesthesia—Doxorubicin—testicular cancer	0.000513	0.000774	CcSEcCtD
Cabergoline—Dyspnoea—Doxorubicin—testicular cancer	0.00051	0.000769	CcSEcCtD
Cabergoline—Feeling abnormal—Epirubicin—testicular cancer	0.000509	0.000768	CcSEcCtD
Cabergoline—Somnolence—Doxorubicin—testicular cancer	0.000508	0.000767	CcSEcCtD
Cabergoline—Gastrointestinal pain—Epirubicin—testicular cancer	0.000505	0.000762	CcSEcCtD
Cabergoline—Dyspepsia—Doxorubicin—testicular cancer	0.000503	0.000759	CcSEcCtD
Cabergoline—Decreased appetite—Doxorubicin—testicular cancer	0.000497	0.00075	CcSEcCtD
Cabergoline—Fatigue—Doxorubicin—testicular cancer	0.000493	0.000743	CcSEcCtD
Cabergoline—Pain—Doxorubicin—testicular cancer	0.000489	0.000737	CcSEcCtD
Cabergoline—Constipation—Doxorubicin—testicular cancer	0.000489	0.000737	CcSEcCtD
Cabergoline—Abdominal pain—Epirubicin—testicular cancer	0.000488	0.000737	CcSEcCtD
Cabergoline—Hypersensitivity—Methotrexate—testicular cancer	0.000486	0.000734	CcSEcCtD
Cabergoline—Asthenia—Methotrexate—testicular cancer	0.000474	0.000715	CcSEcCtD
Cabergoline—Feeling abnormal—Doxorubicin—testicular cancer	0.000471	0.000711	CcSEcCtD
Cabergoline—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000467	0.000705	CcSEcCtD
Cabergoline—Pruritus—Methotrexate—testicular cancer	0.000467	0.000705	CcSEcCtD
Cabergoline—Hypersensitivity—Epirubicin—testicular cancer	0.000455	0.000687	CcSEcCtD
Cabergoline—Abdominal pain—Doxorubicin—testicular cancer	0.000452	0.000682	CcSEcCtD
Cabergoline—Diarrhoea—Methotrexate—testicular cancer	0.000452	0.000681	CcSEcCtD
Cabergoline—Asthenia—Epirubicin—testicular cancer	0.000443	0.000669	CcSEcCtD
Cabergoline—Pruritus—Epirubicin—testicular cancer	0.000437	0.000659	CcSEcCtD
Cabergoline—Dizziness—Methotrexate—testicular cancer	0.000437	0.000659	CcSEcCtD
Cabergoline—Diarrhoea—Epirubicin—testicular cancer	0.000423	0.000638	CcSEcCtD
Cabergoline—Hypersensitivity—Doxorubicin—testicular cancer	0.000421	0.000635	CcSEcCtD
Cabergoline—Vomiting—Methotrexate—testicular cancer	0.00042	0.000633	CcSEcCtD
Cabergoline—Rash—Methotrexate—testicular cancer	0.000416	0.000628	CcSEcCtD
Cabergoline—Dermatitis—Methotrexate—testicular cancer	0.000416	0.000627	CcSEcCtD
Cabergoline—Headache—Methotrexate—testicular cancer	0.000414	0.000624	CcSEcCtD
Cabergoline—Asthenia—Doxorubicin—testicular cancer	0.00041	0.000619	CcSEcCtD
Cabergoline—Dizziness—Epirubicin—testicular cancer	0.000409	0.000616	CcSEcCtD
Cabergoline—Pruritus—Doxorubicin—testicular cancer	0.000404	0.00061	CcSEcCtD
Cabergoline—Vomiting—Epirubicin—testicular cancer	0.000393	0.000593	CcSEcCtD
Cabergoline—Nausea—Methotrexate—testicular cancer	0.000392	0.000592	CcSEcCtD
Cabergoline—Diarrhoea—Doxorubicin—testicular cancer	0.000391	0.00059	CcSEcCtD
Cabergoline—Rash—Epirubicin—testicular cancer	0.00039	0.000588	CcSEcCtD
Cabergoline—Dermatitis—Epirubicin—testicular cancer	0.000389	0.000587	CcSEcCtD
Cabergoline—Headache—Epirubicin—testicular cancer	0.000387	0.000584	CcSEcCtD
Cabergoline—Dizziness—Doxorubicin—testicular cancer	0.000378	0.00057	CcSEcCtD
Cabergoline—Nausea—Epirubicin—testicular cancer	0.000367	0.000554	CcSEcCtD
Cabergoline—Vomiting—Doxorubicin—testicular cancer	0.000363	0.000548	CcSEcCtD
Cabergoline—Rash—Doxorubicin—testicular cancer	0.00036	0.000544	CcSEcCtD
Cabergoline—Dermatitis—Doxorubicin—testicular cancer	0.00036	0.000543	CcSEcCtD
Cabergoline—Headache—Doxorubicin—testicular cancer	0.000358	0.00054	CcSEcCtD
Cabergoline—Nausea—Doxorubicin—testicular cancer	0.00034	0.000512	CcSEcCtD
